Syntheses of carbocyclic uracil polyoxin C analogs: Application of Pd(0)/InI-allylation of 4-acetoxy-2-azetidinone

Journal of Organic Chemistry

Volumn 74, Issue 15, 2009, Pages 5730-5733

  Cesario, Cara ^a   Miller, Marvin J ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLYLATION; CYCLOADDUCT; HETERO-DIELS; SIDE CHAINS;

AMINES; AMINO ACIDS; ORGANIC ACIDS;

PALLADIUM;

4 ACETOXY 2 AZETIDINONE; ANTIFUNGAL AGENT; AZETIDINONE DERIVATIVE; BETA AMINO ACID; CARBOCYCLIC URACIL POLYOXIN C DERIVATIVE; INDIUM; IODINE; PALLADIUM; UNCLASSIFIED DRUG;

ALLYLATION; ARTICLE; CYCLIZATION; DIELS ALDER REACTION; DRUG STRUCTURE; DRUG SYNTHESIS; STEREOCHEMISTRY;

AZETIDINES; INDIUM; MOLECULAR STRUCTURE; PALLADIUM; PYRIMIDINE NUCLEOSIDES; STEREOISOMERISM; URACIL;

EID: 68049114668     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo900861x     Document Type: Article

References (36)

1. For a review of synthetic methods, see: Zhang, D.; Miller, M. J. Curr. Pharm. Design 1999, 5, 73-99.
2. Chitin synthase as an antifungal target, see: (a) Ruiz-Herrera, J.; San-Blas, G. Curr. Drug Targets- Infectious Disorders 2003, 3, 77-91.
3. (b) Behr, J.-B. Curr. Med. Chem.- Anti-Infective Agents 2003, 2, 173-189.
4. Ruiz-Herrera, J. Fungal Cell Wall: Structure, Synthesis and Assembly; CRC Press: Boca Raton, 1992.
5. Gooday, G. W. In The Biochemistry of Cell Walls and Membranes in Fungi; Goosey, M., Kuhn, P., Trinci, A. P. J., Eds.; Springer-Verlag: Berlin, 1989; pp 61-76.
6. Naider, F.; Becker, J. M. In Current Topics in Medical Mycology II; McGinnis, M. M., Ed.; Springer: Berlin, 1987; pp 170-198.
7. Shenbagamurthi, P.; Smith, H. A.; Becker, J. M.; Naider, F. J. Med. Chem. 1986, 29, 802-809.
8. Emmer, G.; Ryder, N. S.; Grassberger, M. A. J. Med. Chem. 1985, 28, 278-281.
9. Azuma, T.; Isono, K.; Crain, P. F.; McCloskey, J. A. J. Chem. Soc., Chem. Comm. 1977, 5, 159-160.
10. (a) Krainer, E.; Becker, J. M.; Naider, F. J. Med. Chem. 1991, 34, 174-180.
11. (b) Naider, F.; Shenbagamurthi, P.; Steinfeld, A. S.; Smith, H. A.; Boney, C.; Becker, J. M. Antimicrob. Agents Chemother. 1983, 24, 787-796.
12. (a) Casu, F.; Chiacchio, M. A.; Romeo, R.; Gumina, G. Curr. Org. Chem. 2007, 11, 999-1016.
13. (b) Jeong, L. S.; Lee, J. A. Antivir. Chem. Chemoth. 2004, 15, 235-250.
14. (c) Rodriguez, J. B.; Comin, M. J. Mini-Rev. Med. Chem. 2003, 3, 95-114.
15. (d) Marquez, V. E.; Lim, M. I. Med. Res. Rev. 1986, 6, 1-40.
16. (a) Li, F.; Brogan, J. B.; Gage, J. L.; Zhang, D.; Miller, M. J. J. Org. Chem. 2004, 69, 4538-4540.
17. (b) Zhang, D.; Miller, M. J. J. Org. Chem. 1998, 63, 755-759.
18. (c) Ward, S. E.; Holmes, A. B.; Ward, S. E.; McCague, R. Chem. Comm. 1997, 21, 2085-2086.
19. (d) Aggarwal, V. K.; Monteiro, N. Org. Biomol. Chem. 1997, 17, 2531-2537.
20. (e) Aggarwal, V. K.; Monteiro, N.; Tarver, G. J.; Lindell, S. D. J. Org. Chem. 1996, 61, 1192-1193.
21. Cesario, C.; Miller, M. J. Org. Lett. 2009, 11, 1293-1295.
22. Isono, K.; Asahi, K.; Suzuki, S. J. Am. Chem. Soc. 1969, 91, 7490-7505.
23. Hori, M.; Kakiki, K.; Misato, T. Agric. Biol. Chem. 1974, 38, 699-705.
24. Cesario, C.; Tardibono, L. P.; Miller, M. J. J. Org. Chem. 2009, 74, 448-451.
25. For a detailed preparation of acyl isocyanate 6, refer to experimental section or see: Santana, L.; Teijeira, M.; Uriarte, E. J. Heterocyclic Chem. 1999, 36, 293-295.
26. (a) Woulfe, S. R.; Miller, M. J. J. Org. Chem. 1986, 51, 3133-3139.
27. (b) Woulfe, S. R.; Iwagami, H.; Miller, M. J. Tetrahedron Lett. 1985, 3, 3891-3894.
28. Shah, N. V.; Cama, L. D. Heterocycles 1987, 25, 221-227.
29. For preparation of N-methylthiophthalimide 9, refer to Supporting Information.
30. Recently, a class of N-alkylthio b-lactams demonstrated anticancer activity. For recent examples of N-alkylthio β-lactams as anticancer agents, see: (a) Kuhn, D. J.; Wang, Y.; Minic, V.; Coates, C.; Reddy; Kumar, G.; Daniel, K. G.; Shim, J.-Y.; Chen, D.; Landis-Piwowar, K. R.; Miller, F. R.; Turos, E.; Dou, Q. P. Front. Biosci. 2005, 10, 1183-1190.
31. (b) Kazi; Hill, R; Long, T. E.; Kuhn, D. J.; Turos, E.; Dou, Q. P. Biochem. Pharmacol. 2004, 67, 365-374.
32. (c) Smith, D. M.; Aslamuzzaman, K.; Smith, L.; Long, T. E.; Heldreth, B.; Turos, E.; Dou, Q. P. Mol. Pharamacol. 2002, 61, 1348-1358.
33. 4-mediated dihydroxylation occurs from opposite face of the allylic methine protons and syn-tetrasubstituted cyclopentanes result. For compound 8, J=6.8 Hz and all syn diastereomer 1b was obtained as the major product after dihydroxylation. For an explanation of how 1,4-disubstituted cyclopentene conformations are determined from coupling constants, see: Katagiri, N.; Ito, Y.; Kitano, K.; Toyota, A.; Kaneko, C. Chem. Pharm. Bull. 1994, 42, 2653-2633.
34. Woodward, R. B.; Brutcher, F. V. Jr. J. Am. Chem. Soc. 1958, 80, 209-211.
35. 4 dihydroxylation, see: Corey, E. J.; Das, J. Tetrahedron Lett. 1982, 23, 4217-4220.
36. Barkley, J. V.; Dhanda, A.; Knutsen, L. J. S.; Nielsen, M. B.; Roberts, S. M.; Varley, D. R. Chem. Commun. 1998, 10, 1117-1118.